AngioDynamics ANGO recently announced expanded indications in Europe for its NanoKnife System, broadening its clinical ...

The phase 2 ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT-PC) trial tested a cooled laser focal therapy device for intermediate-risk prostate cancer treatment.

The NanoKnife system employs non-thermal IRE ablation to destroy tumour cells while preserving surrounding anatomy.

Add Yahoo as a preferred source to see more of our stories on Google. Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug ...

In the absence of a trial, a matched analysis compared cancer control after salvage focal therapy vs radical prostatectomy (RP) for radiorecurrent prostate cancer.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

Australia: Researchers have found in a systematic review and meta-analysis that focal laser ablation offers oncological ...

Prostate cancers are either low-grade, low-risk forms that may be monitored but otherwise untreated, or they’re serious enough to require surgery and radiation. Monitoring can cause patients anxiety.

Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation - the precise application of heat via laser to a tumor - ...

Steam may be more powerful than you think. It smooths clothes and kills germs, but now doctors are testing it against cancer. At Keck Medicine of USC, part of a large nationwide study, researchers are ...

High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...